Innovation Ventures ☰
  • Partnering Opportunities
  • Innovator
  • Partner
  • Investor
  • About

Refine by

Category
Technology Type
Area of Interest
Stage of Development
Patent Status

Partnering Opportunities


  • Genetic Diseases

    Novel Treatment to Ensure Efficacious Dosage for Multiple, Rare Genetic Diseases

    Optimal dosing regimen for treating seizures and self-aggressive behavior

  • Obstetrics

    Druggable Target for Premature Birth

    Analysis of the genetic factors that contribute to the duration of gestation and risk of preterm birth has led to identification of druggable targets to prevent preterm birth.

  • Anti-Aging

    Cell Longevity Treatment with a Cdc42 specific inhibitor

    CASIN significantly increases murine lifespan and epigenetic clock.

  • Pulmonology

    Airway Clearance Technology for Patients with Chronic Lung Diseases

    Rapid and highly effective mucus clearance from airways without active coughing.

  • Oncology

    Small Molecule Vav3 inhibitor as Novel Cancer Therapeutic

    Our proprietary inhibitor binds to Vav3 thereby inhibiting the activation of Rac and the estrogen receptor.

  • Gene and Cell therapy

    Stem Cell & Organoid Medicine

    Organoids provide an unprecedented opportunity to study human organ development and physiology, and investigate the cause of disease.

  • Genetics Immunology

    Complement 5a increases inflammation in Hunter Syndrome

    Complement 5a increases inflammation in Hunter Syndrome

  • Pulmonology

    Repurposing Barasertib for Idiopathic Pulmonary Fibrosis

    Repurposing a phase I/II compound (AURKB inhibitor - barasertib) for idiopathic pulmonary fibrosis therapy.

  • Immunology

    CAR-NK Therapy for Lupus

    Human Natural Killer cells expressing chimeric antigen receptor that targets aberrant immune system signaling that is involved in auto-antibody production associated with Systemic Lupus Erythematosus.

  • Neurodegenerative Diseases

    Restoring acid-β-glucosidase activity by non-inhibitory small molecule chaperones

    Restore GCase activity in the brain for Gaucher and Parkinson's

Next Page
  • Partnering Opportunities
  • Innovator
  • Partner
  • Investor
  • About

Innovation Ventures | Partnering to Change the Outcome

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4285

© 1999-2021 Cincinnati Children's Hospital Medical Center